Skip main navigation

General questions 7 : Carbamazepine

General questions 7 : Carbamazepine
10.7
General question number seven Carbamazepine and antiepileptic is greater than 99% metabolized to a metabolite which is at 10, 11 epoxide the metabolite has little antiepileptic effect but does cause idiosyncratic adverse reaction so if the drug is given to a patient with GFR of 50 and numbers have compromised of 50% compromised What is your recommendation for the patients dosing regimen? Let’s look through the answers. First the dose should be decreased compared to the standard regimen Well the drug is so extensively metabolized and therefore we really don’t have to worry too much about the dose So A is pretty much out. B the dose should be increased compared to the standard regimen. This is to the opposite.
89.6
No drug should be increased because of because of a compromised renal function and D the drug is contraindicated for a patient with renal insufficiency. This is not the case. And the most likely this type of answer is red herring also. That is a distractor. So let’s look at choice number three. C so standard dose regimen is appropriate for this patient simply because carbamazepine is greater than 99% metabolize since liver is doing a job so in renal failure, we don’t have to worry too much about dosing regimen. Again some PK information is helpful for you to make the right choice.
150.4
We know carbamazepine is 70% absorbed it is 99% metabolized and that the 10, 11 epoxide is further metabolized in the liver and excreted by the kidneys. So in patient was the liver function and liver dysfunction in fact the carbamazepine dosage need to be adjusted not in renal failure but in liver dysfunction. Because the epoxide metabolite may accumulated and this epoxide metabolic causes teratogenic toxicity protein binding is 75% and that we have kinetic information and clearance on volume distribution and on half-life

Continuing from the previous step, Prof. Lee explains the seventh general question this time.

From this case, we can know that Carbamazepine is greater than 99% metabolized, which means liver is the main character to deal with the drug.

As a result, the carbamazepine dosage need to be adjusted not in renal failure but in liver dysfunction.

If you have any questions or thoughts, please do not hesitate to leave them below.

This article is from the free online

Pharmacokinetics: Drug Dosing in Renal Disease

Created by
FutureLearn - Learning For Life

Our purpose is to transform access to education.

We offer a diverse selection of courses from leading universities and cultural institutions from around the world. These are delivered one step at a time, and are accessible on mobile, tablet and desktop, so you can fit learning around your life.

We believe learning should be an enjoyable, social experience, so our courses offer the opportunity to discuss what you’re learning with others as you go, helping you make fresh discoveries and form new ideas.
You can unlock new opportunities with unlimited access to hundreds of online short courses for a year by subscribing to our Unlimited package. Build your knowledge with top universities and organisations.

Learn more about how FutureLearn is transforming access to education